(r)-2-(α-deuterium-α-alkyl-α-aromatic) azaaryl compound and its preparation method and application

A technology of azaaryl and compound, which is applied in the field of synthesis of chiral deuterated compounds, can solve the problem of low stereoselectivity, and achieve the effects of environmental friendliness, high yield and mild reaction conditions

Active Publication Date: 2022-03-22
HENAN NORMAL UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] One of the objects of the present invention is to solve the problem of low stereoselectivity in the synthesis of chiral deuterated compounds in the prior art, and provide a kind of (R)-2-(α-deuterium-α-alkyl-α-aryl) The preparation method of azaaryl compound

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • (r)-2-(α-deuterium-α-alkyl-α-aromatic) azaaryl compound and its preparation method and application
  • (r)-2-(α-deuterium-α-alkyl-α-aromatic) azaaryl compound and its preparation method and application
  • (r)-2-(α-deuterium-α-alkyl-α-aromatic) azaaryl compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] ( R )-2-(2-methyl-1-phenylpropyl-1-d) The concrete preparation steps of quinoline are as follows:

[0027]

[0028] Preparation process: Take a dry 25 mL schlenk tube, add 29.6 mg (0.1 mmol) 2-(1-chloro-2-methyl-1-phenylpropyl) quinoline, DPZ (0.35 mg, 0.001 mmol), CPA ( 1.16 mg, 0.02 mmol), HEH (38 mg, 0.15 mmol), D 2 O (200 mg, 10 mmol), sodium bicarbonate (12.6 mg, 0.15 mmol), then add 3 mL of mesitylene, cover the bottle, and degas with a vacuum pump 2-3 times at no higher than -78°C , each time for 5 to 10 min, then placed at 25°C, irradiated with a 3 W blue light, and reacted for 20 minutes. After the reaction, column chromatography separated (petroleum ether / ethyl acetate = 20~4:1, volume ratio ), concentrated by rotary evaporation, and dried in vacuo (dried at 25°C for 1 hour) to obtain 19.8 mg of white solid ( R )-2-(2-methyl-1-phenylpropyl-1-d)quinoline with a yield of 75%, an enantiomeric excess of 93%, and a deuterated rate of >99%. NMR and mass spect...

Embodiment 2

[0030] ( R )-2-(2-methyl-1-(4-(trifluoromethyl)phenyl) propyl-1-d) quinoline The specific preparation steps are as follows:

[0031]

[0032]In the present example, 2-(1-chloro-2-methyl-1-phenylpropyl)quinoline in Example 1 was used 2-(1-chloro-2-methyl-1-(4-( s trifluoromethyl)) propyl) quinoline replacement, other steps are identical with embodiment 1, obtain 22.4 mg colorless oil ( R )-2-(2-methyl-1-(4-(trifluoromethyl)phenyl)propyl-1-d)quinoline, yield 68%. The enantiomeric excess is 95%, and the deuteration rate is >99%. NMR and mass spectrometry data are: 1 H NMR (300 MHz, CDCl 3 ) δ 8.28 – 7.95 (m, 2H), 7.81 – 7.59 (m,4H), 7.51 – 7.45 (m, 3H), 7.34 (d, J = 8.4 Hz, 1H), 2.89 – 2.85 (m, 1H), 0.93– 0.85 (m, 6H); 13 C NMR (75 MHz, CDCl 3 ) Δ 162.8, 147.0, 136.5, 129.4, 129.2,128.8, 127.4, 126.9, 126.0, 125.3, 125.2, 125.2, 121.2,32.2, 21.6, 21.3; HRMS (ESI) M / Z 331.1519 (m +H + ), calc. for C 20 h 18 DF 3 N331.1527.

Embodiment 3

[0034] ( R )-2-(2-methyl-1-(2-naphthyl) propyl-1-d) The concrete preparation steps of quinoline are as follows:

[0035]

[0036] In this example, the 2-(1-chloro-2-methyl-1-phenylpropyl)quinoline in Example 1 was used 2-(1-chloro-2-methyl-1-(2-naphthyl) base) propyl) quinoline to give 22.5 mg colorless oil ( R )-2-(2-methyl-1-(2-naphthyl)propyl-1-d)quinoline in 72% yield, 88% enantiomeric excess, and >99% deuterated rate. NMR and mass spectrometry data are: 1 H NMR (300 MHz, CDCl 3 ) δ 8.13 (d, J = 8.3 Hz, 1H), 8.00 (d, J = 8.6 Hz, 1H), 7.91 (s, 1H),7.84 – 7.63 (m, 6H), 7.50 –7.33 (m, 4H), 3.00 – 2.90 (m, 1H), 0.96 (d, J =6.4 Hz, 6H); 13 C NMR (75 MHz, CDCl 3 ) Δ 163.7, 147.6, 140.4, 136.3, 133.5,132.3, 129.3, 129.1, 127.7, 127.5, 127.0, 126.8, 125.8,125.4, 121.7, 21.7, 21.5; z 313.1802 (M+H + ), calc.forC 23 h 21 DN 313.1810.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of (R)-2-(α-deuterium-α-alkyl-α-aryl) azaaryl compound. During preparation, 2-(α-chloro-α-alkyl ‑α‑aryl) azaarene, photosensitizer DPZ, chiral catalyst CPA, Hans ester HEH, deuterium source and sodium bicarbonate dispersed in an organic solvent, after degassing treatment at no higher than ‑78 °C, Put it at 20~30℃, irradiate with 3~10W blue light, and react for 20~40 minutes. After the reaction, separate and purify to obtain (R)‑2‑(α‑deuterium‑α‑alkyl -α-aryl) azaaryl compounds. The enantiomeric excess of the target product obtained in the present invention is about 90%, the deuterium substitution rate is as high as over 99%, the yield is high, and the reaction conditions are mild and pollution-free.

Description

technical field [0001] The invention belongs to the technical field of synthesis of chiral deuterated compounds, in particular to (R)-2-(α-deuterium-α-alkyl-α-aryl) azaaryl compounds and their preparation methods and applications. Background technique [0002] Deuterium-substituted drugs replace the hydrogen atoms in the molecule with deuterium atoms on the basis of the original drug. Many drugs involve the breaking of the C-H bond in the metabolic clearance mechanism in the body. Therefore, the introduction of deuterium atoms at the metabolic site of the drug can slow down or prevent the breaking of the C-D bond, thereby achieving the purpose of changing the drug metabolism rate or metabolic pathway. Compared with non-deuterated drugs, deuterium-banded drugs can slow down drug metabolism, improve pharmacokinetics, and reduce toxic metabolites. Therefore, the synthesis of deuterated compounds has received a certain amount of attention, especially in April 2017, when the FDA...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D215/12C07D217/02C07D277/64A61P35/00
CPCC07D215/12C07D217/02C07D277/64A61P35/00
Inventor 江智勇
Owner HENAN NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products